Through new NIH grant, School of Pharmacy Assistant Professor Jason Peters and collaborators are investigating bacteria viruses as a way to defeat antibiotic resistance.
Pharmaceutical Sciences
Researcher on the Rise
School of Pharmacy Assistant Professor Quanyin Hu recently earned national honors as a highly cited rising star in drug delivery By Nicole Sweeney Etter The accolades for Quanyin Hu, an assistant professor in the University …
A Continuing Tradition of Innovation
School of Pharmacy researchers in fiscal year 2021–22 received four patents for innovations in drug discovery and delivery.
Exploring New Avenues for Targeted Protein Degradation
Supported by a prestigious national fellowship and UW traineeship, Pharmaceutical Sciences graduate student Christopher Stevens is expanding the application of a future therapeutic.
Photo Gallery: PharmSci 360 Reception
During the annual American Association of Pharmaceutical Scientists’ PharmSci 360 conference, the University of Wisconsin–Madison School of Pharmacy hosted a reception to gather Badger researchers from around the nation to catch up and build new connections.
Probiotic ‘Backpacks’ Show Promise for Treating Inflammatory Bowel Diseases
Combined with the probiotics themselves, newly developed nanoparticle “backpacks” could significantly improve — and simplify — IBD treatments.
Four Alumni are Honored with 2022 Citations of Merit
The School’s highest annual award celebrates alumni and friends for contributions to academia, community pharmacy, and history of pharmacy.
Bridging the Gap Between a Novel Protein and its Cellular Function
Postdoctoral scientist Sarah Neuman and Professor Arash Bashirullah find bridge-shaped proteins that channel the flow of essential lipids inside cells.
Leadership, Learning, and Drug Development
Alum Elham Nejati (PhD ’12) advances new therapeutics through formulation and process development at Gilead Sciences.
New Injectable Gel Treatment Offers Promise for Tough-to-Treat Brain Tumors
School of Pharmacy Assistant Professor Quanyin Hu and collaborators publish preclinical results on a new approach to prevent glioblastoma recurrence.